Drug Development and Regulation in the Age of Precision Medicine


An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory science graduate program and courses. Plus, a deep dive into precision medicine as a disruptive force across all aspects of the health care system. Specifically, how the development of precision medicine based-therapies continue to pose challenges related to scientific discovery, diagnostic regulatory policy, investment incentives, coverage and reimbursement, and the implementation of new technologies into clinical practice.

Presenters: John-Michael Sauer, PhD, C-Path Biomarker Program Officer and Executive Director of the Predictive Safety Testing Consortium

Tara Sklar, JD, MPH, Professor of Health Law, Director, Health Law & Policy Program

Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020